Indacaterol/glycopyrronium increases lung ventilation in COPD patients as measured by hyperpolarized 3He MRI

H. Tillmann (Basel, Switzerland), D. Singh (Manchester, United Kingdom), D. Saralaya (Bradford, United Kingdom), R. Lawson (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), J. Goldin (Los Angeles, United States of America), K. Kostikas (Basel, Switzerland), K. Smith (Cambridge, United States of America), S. Machineni (Hyderabad, India), D. Yates (Cambridge, United States of America)

Source: International Congress 2018 – COPD management
Session: COPD management
Session type: Thematic Poster
Number: 4378
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Tillmann (Basel, Switzerland), D. Singh (Manchester, United Kingdom), D. Saralaya (Bradford, United Kingdom), R. Lawson (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), J. Goldin (Los Angeles, United States of America), K. Kostikas (Basel, Switzerland), K. Smith (Cambridge, United States of America), S. Machineni (Hyderabad, India), D. Yates (Cambridge, United States of America). Indacaterol/glycopyrronium increases lung ventilation in COPD patients as measured by hyperpolarized 3He MRI. 4378

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: